See All Slides - tctmd.com

Slides

Presentation

Prognostic Value of Access and Non-Access Site Bleeding After PCI

Presenter: 201973|Gjin Ndrepepa

July 26, 2013

Presentation

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Presenter: David Garcia

August 05, 2013

Presentation

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Presenter: Gert Richardt

August 14, 2013

Presentation

Evidence Against the Involvement of Chronic Cerebrospinal Venous Abnormalities in MS

Presenter: I. Rodger

August 15, 2013

Presentation SOLACI 2013

DAPT for ACS: Focus on Patient Secondary Prevention

Presenter: Roberto Botelho

July 24, 2013

Presentation SOLACI 2013

New Devices for Ventricular Assistance

Presenter: Breno de Alencar Araripe Falc?o

July 24, 2013

Presentation SOLACI 2013

How to Improve Safety on Current PCI and DES Scenario: From Radial Approach to Imaging Guidance

Presenter: M. Vald?s Ch?varri

July 25, 2013

Presentation SOLACI 2013

Global Penetration of TRI Overview

Presenter: Shigeru Saito

July 25, 2013

Presentation TCT 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presenter: Subhash Banerjee, Rick Weideman, Bertis Little, Mark Weideman, Jennifer Gunter, Kevin Kelly, Emmanouil Brilakis

January 31, 2013

Presentation TCT 2013

Large 22 to 24Fr femoral vein hemostasis with a subcutaneous stitch or a double Perclose closure is effective and safe.

Presenter: Asma Hussaini, Wen Loong Yeow, Takashi Matsumoto, Mamoo Nakamura, Hassan Jlaihawi, Raj Makkar, Saibal Kar

January 31, 2013

Advertisement

Slides

Prognostic Value of Access and Non-Access Site Bleeding After PCI

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Evidence Against the Involvement of Chronic Cerebrospinal Venous Abnormalities in MS

DAPT for ACS: Focus on Patient Secondary Prevention

New Devices for Ventricular Assistance

How to Improve Safety on Current PCI and DES Scenario: From Radial Approach to Imaging Guidance

Global Penetration of TRI Overview

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Large 22 to 24Fr femoral vein hemostasis with a subcutaneous stitch or a double Perclose closure is effective and safe.

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content